Effects of reducing blood pressure on cardiovascular outcomes and mortality in patients with type 2 diabetes: Focus on SGLT2 inhibitors and EMPA-REG OUTCOME-Reference-Cited by-同舟云学术

Effects of reducing blood pressure on cardiovascular outcomes and mortality in patients with type 2 diabetes: Focus on SGLT2 inhibitors and EMPA-REG OUTCOME

Published:2016-11 Issue: Volume:121 Page:204-214
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Scheen André J.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference78 articles.

1. Diabetes and hypertension: the bad companions;Ferrannini;Lancet,2012

2. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data;Blood Pressure Lowering Treatment Trialists C;Lancet,2014

3. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25million people;Rapsomaniki;Lancet,2014

4. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38;UK Prospective Diabetes Study Group;BMJ,1998

5. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34;UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Cardiac Function Outcomes in Non-Diabetic Heart Failure Patients Treated with SGLT2 Inhibitors;Journal of Korean Society of Health-System Pharmacists;2024-08-31

2. TFRC in cardiomyocytes promotes macrophage infiltration and activation during the process of heart failure through regulating Ccl2 expression mediated by hypoxia inducible factor‐1α;Immunity, Inflammation and Disease;2023-08

3. The current role of SGLT2 inhibitors in type 2 diabetes and beyond: a narrative review;Expert Review of Endocrinology & Metabolism;2023-05-08

4. Management of traditional risk factors for the development and progression of chronic kidney disease;Clinical Kidney Journal;2023-04-26

5. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis;The Lancet Diabetes & Endocrinology;2022-09